FDA issued a Warning Letter to Abbott's Compounding Pharmacy, Inc. on 4/4/2017 as a result of this inspection.
FDA investigators audited the Abbott's Compounding Pharmacy - Berkeley, CA, United States facility and issued 11 inspectional observations (via FDA 483) on 08 Jan 2016.
Add To Cart
- Category: Human Drugs
- Number of Observations: 11
- Inspection end: 08 Jan 2016
- Location: Berkeley, United States
- FEI: 3005529620